دورية أكاديمية
أعرض في EDS

The striatal balancing act in drug addiction: distinct roles of direct and indirect pathway medium spiny neurons.

التفاصيل البيبلوغرافية
العنوان: The striatal balancing act in drug addiction: distinct roles of direct and indirect pathway medium spiny neurons.
المؤلفون: Lobo MK; Fishberg Department of Neuroscience, Friedman Brain Institute, Mount Sinai School of Medicine New York, NY, USA., Nestler EJ
المصدر: Frontiers in neuroanatomy [Front Neuroanat] 2011 Jul 18; Vol. 5, pp. 41. Date of Electronic Publication: 2011 Jul 18 (Print Publication: 2011).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101477943 Publication Model: eCollection Cited Medium: Internet ISSN: 1662-5129 (Electronic) Linking ISSN: 16625129 NLM ISO Abbreviation: Front Neuroanat Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Lausanne, Switzerland : Frontiers Research Foundation, 2007-
مستخلص: The striatum plays a key role in mediating the acute and chronic effects of addictive drugs, with drugs of abuse causing long-lasting molecular and cellular alterations in both dorsal striatum and nucleus accumbens (ventral striatum). Despite the wealth of research on the biological actions of abused drugs in striatum, until recently, the distinct roles of the striatum's two major subtypes of medium spiny neurons (MSNs) in drug addiction remained elusive. Recent advances in cell-type-specific technologies, including fluorescent reporter mice, transgenic, or knockout mice, and viral-mediated gene transfer, have advanced the field toward a more comprehensive understanding of the two MSN subtypes in the long-term actions of drugs of abuse. Here we review progress in defining the distinct molecular and functional contributions of the two MSN subtypes in mediating addiction.
References: J Neurosci. 2002 Sep 15;22(18):8133-8. (PMID: 12223567)
Nat Chem Biol. 2006 Jan;2(1):47-52. (PMID: 16408092)
J Neurosci. 2006 Dec 20;26(51):13287-96. (PMID: 17182779)
Proc Natl Acad Sci U S A. 1991 May 15;88(10):4205-9. (PMID: 1827915)
Science. 1990 Dec 7;250(4986):1429-32. (PMID: 2147780)
Trends Neurosci. 1989 Oct;12(10):366-75. (PMID: 2479133)
Nat Neurosci. 2009 Mar;12(3):247-9. (PMID: 19234455)
J Neurosci. 1992 Sep;12(9):3591-600. (PMID: 1527598)
Nat Neurosci. 2006 Mar;9(3):443-52. (PMID: 16491081)
Nat Methods. 2010 Aug;7(8):595, 597. (PMID: 20676078)
Genesis. 2008 Jul;46(7):357-67. (PMID: 18615733)
Trends Neurosci. 2006 Dec;29(12):695-703. (PMID: 17084911)
J Exp Anal Behav. 1997 May;67(3):337-51. (PMID: 9163938)
J Neuroendocrinol. 2008 May;20 Suppl 1:10-4. (PMID: 18426493)
Neuroreport. 1996 Dec 20;8(1):1-5. (PMID: 9051741)
Brain Res. 2006 Mar 10;1077(1):67-80. (PMID: 16516871)
Psychopharmacology (Berl). 2009 Oct;206(3):469-78. (PMID: 19641899)
Nat Neurosci. 2001 Dec;4(12):1217-23. (PMID: 11694884)
J Neurosci. 2007 Jul 25;27(30):7921-8. (PMID: 17652583)
Nature. 2009 Sep 3;461(7260):104-8. (PMID: 19693014)
Annu Rev Neurosci. 2011;34:441-66. (PMID: 21469956)
Nature. 2010 Jul 29;466(7306):622-6. (PMID: 20613723)
Nature. 2009 Apr 23;458(7241):1025-9. (PMID: 19295515)
Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3399-404. (PMID: 16492766)
Nat Neurosci. 2009 Apr;12(4):393-5. (PMID: 19270687)
Pharmacol Biochem Behav. 2001 Apr;68(4):797-803. (PMID: 11526979)
Science. 1996 Mar 15;271(5255):1586-9. (PMID: 8599115)
Behav Brain Res. 1999 Sep;103(2):203-9. (PMID: 10513588)
Biol Psychiatry. 2011 Jun 1;69(11):1026-34. (PMID: 21377654)
Cell. 2008 Nov 14;135(4):738-48. (PMID: 19013281)
Science. 1998 Aug 7;281(5378):838-42. (PMID: 9694658)
Science. 2010 Jan 8;327(5962):213-6. (PMID: 20056891)
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11042-6. (PMID: 11572966)
Eur J Neurosci. 2001 May;13(10):1977-83. (PMID: 11403691)
Nature. 1997 Aug 7;388(6642):586-9. (PMID: 9252189)
J Neurosci. 2003 Jun 1;23(11):4785-90. (PMID: 12805318)
Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6840-5. (PMID: 17426149)
Appetite. 2000 Feb;34(1):87-94. (PMID: 10744895)
J Pharmacol Exp Ther. 1995 Dec;275(3):1671-80. (PMID: 8531143)
Nat Protoc. 2010 Feb;5(2):247-54. (PMID: 20134425)
Synapse. 1997 Dec;27(4):357-66. (PMID: 9372558)
Eur J Pharmacol. 1998 Jul 24;353(2-3):149-58. (PMID: 9726645)
Nat Neurosci. 2007 Aug;10(8):1029-37. (PMID: 17618281)
Neurosci Lett. 1991 Sep 16;130(2):177-81. (PMID: 1795877)
Nat Rev Neurosci. 2004 Jun;5(6):483-94. (PMID: 15152198)
Neuron. 1994 Nov;13(5):1235-44. (PMID: 7946359)
Brain Res. 2003 Apr 25;970(1-2):73-86. (PMID: 12706249)
Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3245-55. (PMID: 18640924)
Proc Natl Acad Sci U S A. 1990 Jan;87(1):230-4. (PMID: 2296581)
Trends Neurosci. 2007 May;30(5):228-35. (PMID: 17408758)
Brain Res. 2001 Nov 30;920(1-2):106-16. (PMID: 11716816)
J Neurosci. 1998 Jan 1;18(1):488-98. (PMID: 9412525)
Pharmacopsychiatry. 2009 May;42 Suppl 1:S69-78. (PMID: 19434558)
Nature. 1999 Sep 16;401(6750):272-6. (PMID: 10499584)
Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1291-5. (PMID: 1825356)
Nat Neurosci. 2011 Jan;14(1):22-4. (PMID: 21131952)
Annu Rev Neurosci. 1992;15:285-320. (PMID: 1575444)
Nat Neurosci. 2008 Aug;11(8):932-9. (PMID: 18622401)
Brain Behav Immun. 2011 Jun;25 Suppl 1:S21-8. (PMID: 21256955)
J Neurosci. 2007 Nov 28;27(48):13140-50. (PMID: 18045908)
Behav Brain Res. 2007 Dec 28;185(2):88-98. (PMID: 17720257)
J Neurosci. 1999 May 15;19(10):4110-22. (PMID: 10234039)
J Neurophysiol. 1992 Sep;68(3):767-77. (PMID: 1359024)
Neuroscience. 1996 Oct;74(3):813-23. (PMID: 8884777)
Nature. 1984 Oct 4-10;311(5985):461-4. (PMID: 6207434)
J Neurosci. 2000 Dec 1;20(23):8701-9. (PMID: 11102476)
Trends Neurosci. 2010 Jun;33(6):267-76. (PMID: 20207024)
Methods Mol Biol. 2009;530:325-42. (PMID: 19266340)
Nat Neurosci. 2010 Jun;13(6):745-52. (PMID: 20473292)
Nat Neurosci. 2005 Nov;8(11):1445-9. (PMID: 16251986)
J Neurosci. 2010 Sep 8;30(36):11973-82. (PMID: 20826661)
Nat Rev Neurosci. 2009 Aug;10(8):561-72. (PMID: 19571793)
Neuropharmacology. 2009;56 Suppl 1:3-8. (PMID: 18617195)
J Neurosci. 1996 Feb 15;16(4):1550-60. (PMID: 8778304)
J Neurosci. 1996 Oct 15;16(20):6579-91. (PMID: 8815934)
Neuron. 2010 Jun 24;66(6):896-907. (PMID: 20620875)
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6814-9. (PMID: 19342491)
Psychopharmacology (Berl). 2008 Aug;199(2):169-82. (PMID: 18551281)
Pharmacol Biochem Behav. 2000 Dec;67(4):693-9. (PMID: 11166059)
Mol Pharmacol. 1998 Sep;54(3):495-503. (PMID: 9730908)
Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4206-11. (PMID: 21368124)
Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14845-50. (PMID: 20682746)
J Neurosci. 2002 Apr 1;22(7):2977-88. (PMID: 11923462)
Nature. 2007 Feb 8;445(7128):643-7. (PMID: 17287809)
Neuron. 1999 Jul;23(3):435-47. (PMID: 10433257)
J Neurosci. 1992 Jul;12(7):2609-22. (PMID: 1613551)
Eur J Neurosci. 2008 May;27(9):2229-40. (PMID: 18430032)
Can J Neurol Sci. 1991 Aug;18(3 Suppl):380-3. (PMID: 1682022)
Synapse. 2008 Jul;62(7):481-6. (PMID: 18418874)
Neuropharmacology. 2008 Aug;55(2):230-7. (PMID: 18614186)
Eur J Neurosci. 1992;4(4):376-380. (PMID: 12106364)
Trends Genet. 1992 Oct;8(10):341-4. (PMID: 1475845)
J Neurosci. 2008 May 28;28(22):5671-85. (PMID: 18509028)
J Neurosci. 2004 Nov 24;24(47):10594-602. (PMID: 15564575)
Nat Neurosci. 2007 Nov;10(11):1395-7. (PMID: 17934457)
Biol Psychiatry. 2009 Apr 15;65(8):696-701. (PMID: 18990365)
Nature. 2008 Jul 3;454(7200):118-21. (PMID: 18500330)
Trends Neurosci. 2009 Oct;32(10):538-47. (PMID: 19765834)
J Neurosci. 2010 Feb 10;30(6):2396-405. (PMID: 20147565)
Nat Neurosci. 2006 Feb;9(2):205-11. (PMID: 16415864)
Psychopharmacology (Berl). 2002 Aug;163(1):54-61. (PMID: 12185400)
J Comp Neurol. 1996 Oct 07;374(1):70-83. (PMID: 8891947)
J Neurosci. 1993 Mar;13(3):1080-7. (PMID: 7680065)
J Neurosci. 2011 Mar 16;31(11):4251-9. (PMID: 21411666)
J Neurosci. 2005 Jul 13;25(28):6651-7. (PMID: 16014726)
Neurotox Res. 2010 Nov;18(3-4):393-409. (PMID: 20361291)
Neuropsychopharmacology. 2006 Dec;31(12):2660-8. (PMID: 16407894)
J Neurosci. 2002 Jul 15;22(14):5817-22. (PMID: 12122043)
Nature. 2003 Oct 30;425(6961):917-25. (PMID: 14586460)
Science. 2010 Oct 15;330(6002):385-90. (PMID: 20947769)
Nat Neurosci. 2010 Aug;13(8):958-66. (PMID: 20601948)
J Neurochem. 2004 Oct;91(2):337-48. (PMID: 15447667)
J Neurosci. 2007 Sep 12;27(37):9817-23. (PMID: 17855595)
Nat Neurosci. 2009 Aug;12(8):1069-73. (PMID: 19620976)
Neuroscience. 1998 Sep;86(1):13-22. (PMID: 9692739)
Alcohol Clin Exp Res. 2004 May;28(5):720-8. (PMID: 15166646)
Mol Psychiatry. 2004 Jun;9(6):557-69. (PMID: 15098002)
Neuroreport. 1995 Nov 27;6(17):2314-6. (PMID: 8747144)
J Neurosci. 2011 Jan 5;31(1):126-32. (PMID: 21209197)
Curr Biol. 2000 Jul 13;10(14):R509-11. (PMID: 10899013)
Annu Rev Neurosci. 1986;9:357-81. (PMID: 3085570)
Exp Neurol. 2011 Mar;228(1):118-25. (PMID: 21192928)
PLoS Biol. 2007 Oct;5(10):e269. (PMID: 17927447)
J Neurosci. 2008 Nov 26;28(48):12808-14. (PMID: 19036973)
J Pharmacol Exp Ther. 1995 Apr;273(1):445-54. (PMID: 7714800)
BMC Neurosci. 2007 Jan 03;8:4. (PMID: 17201924)
Psychopharmacology (Berl). 2000 Oct;152(3):343-50. (PMID: 11105945)
Neuroreport. 1997 Jul 28;8(11):2523-7. (PMID: 9261820)
J Exp Anal Behav. 1993 Jul;60(1):219-38. (PMID: 8354968)
J Neurosci. 2002 May 15;22(10):RC224. (PMID: 12006606)
Neuropharmacology. 2010 Jun;58(7):1067-77. (PMID: 20176040)
Brain Res. 1988 Sep 13;460(1):161-7. (PMID: 2464402)
معلومات مُعتمدة: P01 DA008227 United States DA NIDA NIH HHS; P50 MH096890 United States MH NIMH NIH HHS; R01 DA007359 United States DA NIDA NIH HHS; R01 DA014133 United States DA NIDA NIH HHS
فهرسة مساهمة: Keywords: D1+ MSNs; D2+ MSNs; addiction; cell-type-specific; cocaine; dopamine; medium spiny neurons; nucleus accumbens
تواريخ الأحداث: Date Created: 20110804 Date Completed: 20111110 Latest Revision: 20220309
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC3140647
DOI: 10.3389/fnana.2011.00041
PMID: 21811439
قاعدة البيانات: MEDLINE
الوصف
تدمد:1662-5129
DOI:10.3389/fnana.2011.00041